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Abstract 1 
Streptomyces coelicolor is a Gram-positive microorganism often used as a model of physiological 2 
and morphological differentiation in streptomycetes, prolific producers of secondary metabolites 3 
with important biological activities. In the present study, we analysed Streptomyces coelicolor 4 
growth and differentiation in the presence of the hypo-methylating agent 5’-aza-2’-deoxycytidine 5 
(5-aza-dC) in order to investigate whether cytosine methylation has a role in differentiation. We 6 
found that cytosine demethylation caused a delay in spore germination, aerial mycelium 7 
development, sporulation, as well as a massive impairment of actinorhodin production. Thus, we 8 
searched for putative DNA methyltransferase genes in the genome and constructed a mutant of the 9 
SCO1731 gene. The analysis of the SCO1731::Tn5062 mutant strain demonstrated that inactivation 10 
of SCO1731 leads to a strong decrease of cytosine methylation and almost to the same phenotype 11 
obtained after 5-aza-dC treatment. Altogether, our data demonstrate that cytosine methylation 12 
influences morphological differentiation and actinorhodin production in S. coelicolor and expand 13 
our knowledge on this model bacterial system. 14 
 15 
  16 
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Introduction 1 
Base methylation is a DNA modification present in all kingdoms of life, including bacteria. The 2 
methylation of cytosines is an important epigenetic mark, well known in higher eukaryotes to 3 
control transcriptional regulation that can cause repression or activation of gene expression. The 4 
correct inheritance of epigenetic patterns is crucial to cell processes while atypical DNA 5 
methylation is linked to numerous diseases, disorders and abnormalities
1,2
. DNA methyltransferase 6 
(Dnmt1) and UHRF1 (ubiquitin-like, containing PHD and RING finger domains) are recognized as 7 
the main players in the preservation of DNA methylation in mammals.  8 
In bacteria the majority of DNA methyltransferases described are part of restriction-modification 9 
(RM) systems. A RM system consists of a restriction endonuclease and a DNA (adenine or 10 
cytosine) methyltransferase. Usually, base methylation protects host DNA from DNA cleavage by 11 
the associated endonuclease. ‘Orphan’ DNA methyltransferase genes can be found in many 12 
bacterial genomes and probably derive from ancestral RM systems that lost the cognate restriction 13 
enzyme. Additional roles in regulating several important cellular processes, such as initiation of 14 
DNA replication, DNA repair and gene regulation, were proposed for bacterial adenine 15 
methyltransferases
3-8
. The most famous examples are the adenine DNA methyltransferases Dam 16 
and CcrM. In Escherichia coli Dam is important for gene expression as well as other cellular 17 
processes, like DNA replication initiation and DNA repair
9-11
. In Caulobacter crescentus and other 18 
Alphaproteobacteria CcrM is essential to regulate gene expression and controls more than 10% of 19 
the genes necessary for its cell cycle progression
12
. Recently, roles in regulating gene expression 20 
were also given to orphan cytosine methyltransferases of Helicobacter pylori and Escherichia coli. 21 
In H. pylori an orphan cytosine methyltransferase influences the expression of genes involved in 22 
motility, adhesion, and virulence
13
. In E. coli, the Dcm cytosine methyltransferase controls the 23 
expression of two ribosomal protein genes, the drug resistance transporter gene sugE at early 24 
stationary phase
10,14,15
 and the expression of genes associated with stationary phase
16
.  25 
5-azacytidine (5-azaC) and 5-aza-2'-deoxycytidine (5-aza-dC) are cytosine DNA methylation 26 
inhibitors routinely used to demethylate DNA in a variety of eukaryotes to assess the consequences 27 
of cytosine DNA methylation loss
17,18
. They are nucleoside analogs that are converted 28 
intracellularly to the corresponding 5′-triphosphates upon cell entry; 5-azaC is incorporated into 29 
both RNA and DNA, whereas 5-aza-dC only into DNA
18-22
. When these analogues are 30 
incorporated, cytosine-5 DNA-dependent cytosine methyltransferases are locked on the DNA and 31 
inhibited with the consequence of decreased 5-methylcytosines in newly replicated DNA
20,21
. 32 
Recently, 5-azaC use was applied to E. coli where it was found to modulate transcriptome
23
.  33 
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Streptomycetes are Gram positive soil bacteria with CG rich genomes (70%). They are industrially 1 
very important because they produce two thirds of all clinically relevant secondary metabolites
24
. 2 
Streptomyces coelicolor A(3)2 strain M145 is the best-known species of the Streptomyces genus at 3 
both genetic and molecular level
25-27
 and it has long been considered as the model streptomycete for 4 
studying physiological (antibiotic production) and morphological differentiation. Streptomyces 5 
coelicolor A(3)2 M145 produces three well characterised antibiotics (actinorhodin, blue pigment, 6 
Act; undecylprodigiosin, red pigment, Red; calcium-dependent lipopeptide antibiotic, CDA), and 7 
has been described to encode for up to 30 additional secondary metabolites
28
. S. coelicolor M145 8 
exhibits a complex developmental cycle that includes sporulation and developmentally associated 9 
programmed cell death
29,30
. In a solid culture (i.e. GYM) five different cell types are sequentially 10 
produced: the unigenomic spores, the first mycelium (MI), the second mycelium (MII), aerial cells 11 
and sporulating cells. After spore germination, a viable vegetative mycelium grows on the surface 12 
and within the agar matrix forming the first compartmentalized mycelium that undergoes a highly 13 
ordered PCD. The remaining viable segments of these hyphae enlarge and form the second 14 
multinucleated mycelium MII that comprises (i) the MII substrate that grows within the agar matrix, 15 
(ii) the aerial MII characterized by hydrophobic layers and (iii) the sporulating MII, which 16 
undergoes a second round of PCD followed by spore formation. S. coelicolor life cycle is regulated 17 
at different levels by extracellular signals and quorum sensing-related factors, multiple master 18 
regulators, and biochemical pathways, such as bald, white and sky
27,31,32
, but little is known 19 
regarding the effect of DNA methylation controlling differentiation. 20 
S. coelicolor M145 has a stringent type IV restriction-modification system that cleaves exogenous 21 
methylated DNA, and for its successful transformation it is first necessary to demethylate DNA 22 
constructs in a dam
-
 dcm
-
 mutant strain of E. coli
33
. Recently, an endonuclease capable to bind to 5-23 
methyl-cytosine containing DNA in all sequence contexts was characterized
34
. Years ago, the role 24 
of DNA methyltransferases in Streptomyces antibioticus and S. coelicolor was investigated by 25 
treating the cultures with demethylating agents and it was found that methylation could influence 26 
development and differentiation
35-37
.  27 
In this study, we investigated whether S. coelicolor M145 genome undergoes differential DNA 28 
cytosine methylation during the growth cycle and whether treatment with a demethylating agent (5-29 
aza-dC) could affect growth and differentiation. We found that DNA cytosine methylation is 30 
modulated during development and that demethylation impairs morphological differentiation and 31 
actinorhodin production. Thus, we searched for DNA methyltransferase genes in the genome and 32 
constructed a mutant in a putative DNA methyltransferase gene. Our data showed that in the 33 
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SCO1731::Tn5062 strain, methylation levels decreased and growth and differentiation were 1 
delayed, similarly to the effects caused by the treatment of S. coelicolor M145 with the 2 
demethylating agent. To the best of our knowledge, this is the first study that demonstrates the 3 
involvement of cytosine methylation in the control of morphological and physiological 4 
differentiation in a microorganism. 5 
 6 
RESULTS 7 
DNA cytosine methylation varies during development of Streptomycetes 8 
Genomic DNA was extracted from different developmental stages of S. coelicolor M145, S. 9 
avermitilis ATCC 31267, S. griseus NBRC 102592 and S. lividans 1326 and analyzed by dot blot 10 
assay using the antibody against 5-MeC (Fig. 1). To our surprise, this analysis showed that cytosine 11 
methylation is higher at the MI stage than at the MII stages in all the conditions (solid GYM 12 
cultures and sucrose-free R5A liquid medium) and species analysed (Fig. 1). Aerial hyphae (MII48h) 13 
showed to have the lowest levels of methylated DNA in S. coelicolor development in solid GYM 14 
cultures (Fig. 1a), while MII hyphae (MII55h) showed the lowest methylation levels in liquid 15 
sucrose-free R5A cultures (Fig. 1b).  16 
S. coelicolor M145, S. griseus and S. avermitilis degrade exogenous methylated DNA, while S. 17 
lividans does not
38,39
. S. lividans 1326 and S. coelicolor M145 are different in accepting methylated 18 
DNA, but they have a very similar genome and a similar development
40
. Despite of that, DNA 19 
cytosine methylation during development is comparable in all the Streptomyces species analyzed 20 
(higher at the MI stage), indicating that it does not depend on RM systems. 21 
 22 
Effect of cytosine demethylation using 5-aza-dC on S. coelicolor M145 differentiation 23 
Thus, to assess whether the modulation of cytosine methylation could have a role on morphological 24 
and physiological differentiation, a treatment with the hypomethylating agent 5’-aza-2’-25 
deoxycytidine (5-aza-dC) was performed. Experiments for the set-up of the cytosine DNA 26 
demethylation treatment were carried out, as described in MM. Streptomyces coelicolor M145 27 
cultures were treated with 5 µM of the hypomethylating agent 5-aza-dC every 12h. 28 
Analysis under confocal laser scanning microscopy (CLSM) after SYTO 9 and PI staining 29 
demonstrated that 5-aza-dC reduced spore germination up to 65% in respect to the 95% of the 30 
untreated culture after 9h of growth. After 12h, the spores of the treated culture were germinated as 31 
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those of the untreated culture (Fig. 2 a-c). Growth curves on solid medium of the untreated and the 1 
5-aza-dC treated S. coelicolor M145 cultures revealed that there was a little effect of 5-aza-dC on 2 
bacterial growth for the first 63h; after 63h, the treated culture grew very slowly and remained in 3 
the stationary phase (Fig. 2d). At 72h and 96h the 5-aza-dC treated samples showed the 4 
multinucleated secondary mycelium (MII) characterized by non-septate branching non-sporulating 5 
hyphae (Fig. 2f), while the untreated culture presented spore chains and single spores (Fig. 2e). In 6 
the 5-aza-dC treated culture, the undecylprodigiosin (red pigment) and actinorhodin (blue pigment) 7 
productions were decreased compared to the untreated culture (Fig. 2g-h). 8 
In liquid sucrose-free R5A cultures, the addition of 5-aza-dC caused a decrease of growth rate (Fig. 9 
3a) and a delay in germination; indeed, ungerminated spores were still present at 20h in the treated 10 
culture, as visualized by CLSM (Supplementary Fig. S1). In the 5-aza-dC treated liquid culture, 11 
undecylprodigiosin production started later in the treated culture, but after 100h, the yields were 12 
similar (Fig. 3b), while actinorhodin production was 4-fold decreased and started later in respect to 13 
the untreated culture (Fig. 3c). 14 
So far, these experiments revealed that 5-aza-dC induces a delay in morphological differentiation 15 
both in liquid and solid medium, influencing spore germination, mycelium development and 16 
sporulation; in addition, actinorhodin yield was impaired. 17 
 18 
Construction of a mutant in the putative DNA methyltransferase SCO1731 gene 19 
A bioinformatics search revealed that in S. coelicolor M145 genome there are annotated 38 genes 20 
coding for putative DNA methyltransferases (Table 1). The expression profile of these putative 21 
DNA methyltransferases was compared to the transcriptomic data, previously obtained using the 22 
same growth media
29
. This search revealed that SCO1731 displayed the highest transcription level 23 
among the putative methyltransferase genes in MI and has orthologs in S. lividans 1326 genome 24 
(100% identity), S. avermitilis ATCC 31267 (79%) and S. griseus strain NBRC 102592 (64%).  25 
Thus, since methylation levels were found higher in MI we evaluated if this gene is important for 26 
cytosine methylation by generating a mutant using a cosmid containing the gene interrupted by the 27 
transposon Tn5062
41
. In liquid sucrose-free R5A cultures, disruption of SCO1731 did not 28 
significantly alter the growth kinetics (Fig. 4a) and spore germination (Supplementary Fig. S1) of 29 
the SCO1731::Tn5062 mutant strain, indicating that this gene is not critical for bacterial growth 30 
under the used conditions.  31 
Dot blot analysis demonstrated that the cytosine methylation levels were strongly reduced in the 32 
SCO1731::Tn5062 mutant strain at 20h (MI) (from xx ± SD, to yy ± SD) (Fig.4b). Differently, the 33 
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SCO1731::Tn5062 mutant had a slight effect on cytosine methylation after 55h of growth (MII) 1 
(Supplementary Fig. S2). Actinorhodin (blue pigment) was not observed in the SCO1731 mutant 2 
strain in liquid sucrose-free R5A even after 96h of growth (Fig. 5), revealing that the mutant is 3 
impaired in actinorhodin production. SCO1731::Tn5062 mutant cultures produced 4 
undecylprodigiosin (red color) (Fig. 5). 5 
Likewise, the inactivation of SCO1731 caused a marked delay in morphological and physiological 6 
differentiation on solid GYM (Fig. 6): aerial mycelium formation started at 96h in the 7 
SCO1731::Tn5062 mutant strain compared to the 48h in the wild-type strain; spore chains were not 8 
formed up to 96h in the mutant strain compared to 72h in the wild-type strain; actinorhodin (blue 9 
color) and undecylprodigiosin (red color) were strongly reduced in the mutant strain. 10 
These results indicate that SCO1731 is responsible for methylation of cytosine in MI and it is 11 
involved in the regulation of actinorhodin production and morphological differentiation. 12 
A complemented strain harboring a copy of the SCO1731 ORF and its upstream region large 13 
enough to include the promoter region, was generated. In the SCO1731_compl strain, the 14 
methylation levels were restored to 70% of the wild-type methylation level (Fig. 4b), the 15 
morphological development (aerial mycelium and sporulation) was fully restored (Fig. 6), and 16 
actinorhodin production was reestablished at 96h, but not at 72h (Fig. 5). The control strain, 17 
containing a copy of the empty integrative vector used for complementation (S. coelicolor+pNG3), 18 
showed a normal antibiotic production profile (Fig. 5) and development (Fig. 6), excluding an effect 19 
of pNG3 integration on the phenotypes observed in the SCO1731_compl strain. 20 
 21 
  22 
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Discussion 1 
Cytosine and adenine methylation are epigenetic mechanisms to control gene expression in 2 
eukaryotic and prokaryotic organisms, respectively. While adenine methylation has been largely 3 
studied in many bacterial systems and it was shown to influence crucial vital processes, such as 4 
bacterial cell cycle, only a few studies have so far been published on cytosine methylation in 5 
bacteria, mostly in Escherichia coli 
4,5,16,23
. Years ago, some attempts to find a role for DNA 6 
methyltransferases in S. antibioticus and S. coelicolor were reported. These studies applied different 7 
compounds known to block cytosine methylation (e.g. 5-azacytidine and sinefungin), but no clear 8 
role for cytosine methylation was established
35-37
. Here, we demonstrate that methylation levels are 9 
modulated throughout the growth cycle in both, solid and liquid media. This result is of particular 10 
interest, since S. coelicolor transformation efficiency depends on the methylation status of 11 
exogenous DNA
38-40
. We also demonstrate that the hypo-methylating agent 5’-aza-2’-deoxycytidine 12 
(5-aza-dC) causes a delay in spore germination, aerial mycelium differentiation and sporulation in 13 
solid medium and affects growth and spore germination in liquid medium; in addition, actinorhodin 14 
production is massively impaired in both solid and liquid media; differently, undecylprodigiosin 15 
production is retarded, but the yields in the treated cultures are similar to the untreated ones. 16 
Unfortunately, our results cannot be compared to previous reports using hypo-methylating agents in 17 
Streptomyces
35-37
, since 5-azacytidine is incorporated into both DNA and RNA, and sinefungin is an 18 
inhibitor of SAM-dependent cytosine and adenine methyltransferase, while in our experiments we 19 
used 5-aza-2’-deoxycytidine that is only incorporated in DNA. Thus, the effect we noticed is 20 
essentially due to cytosine methylation in the genome. 21 
We demonstrate that SCO1731 codes for a cytosine methyltransferase involved in the cytosine 22 
methylation accompanying Streptomyces differentiation. In the SCO1731::Tn5062 mutant strain, 23 
cytosine methylation was reduced to 22% compared to the parental strain during the MI stage. Our 24 
results cannot rule out that other methyltransferases may be responsible for residual methylation nor 25 
that other methyltransferases may be expressed following SCO1731 activation in a cascade manner. 26 
In fact, 38 genes coding for putative methyltransferases are present in S. coelicolor genome, making 27 
this a reasonable hypothesis. Among them, SCO1731 was transcribed in MI at higher levels, when 28 
cytosine methylation is higher than in other growth stages both in liquid and solid medium. 29 
Moreover, the SCO1731::Tn5062 mutant shows the same phenotype observed in the 5-aza-2’-30 
deoxycytidine treated cultures regarding the effect on actinorhodin production, aerial mycelium 31 
differentiation and sporulation, that resulted impaired in the SCO1731::Tn5062 mutant and the 5-32 
aza-2’-deoxycytidine treated cultures; differently, the delay observed in undecylprodigiosin 33 
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production, spore germination and growth in the 5-aza-2’-deoxycytidine treated cultures was not 1 
observed in the SCO1731::Tn5062 mutant. This further indicates that SCO1731 is not the only 2 
methyltransferase participating in the regulation of Streptomyces development. Interestingly, the 3 
complemented mutant strain restored partially the methylation levels to 70% and if on the one hand 4 
this was sufficient to restore the correct morphological development, on the other one said 5 
methylation level was not sufficient to re-establish the onset of the actinorhodin production, further 6 
supporting that some other cellular events do occur. This kind of multilevel regulation would be not 7 
far from other bacterial systems, better investigated for influence of DNA methylation on gene 8 
expression. For instance, in C. crescentus many genes are controlled by the CcrM methyltransferase 9 
and are also co-regulated by other global cell cycle regulators, demonstrating an extensive cross talk 10 
between DNA adenine methylation and the complex regulatory network governing cell cycle 11 
progression
12
.  12 
Given that S. coelicolor undergoes a complex life cycle with two programmed cell death events, we 13 
hypothesized that the hypermethylation of genomic DNA in MI could be a signal that activates 14 
DNA cleavage in some cells leading to cell death and allowing a controlled life cycle. In E. coli, it 15 
was demonstrated that cell death occurs upon an induced cytosine hypermethylation of genome
42-44
. 16 
Even if this were the case, it would still be difficult to explain how adjacent cells perceive different 17 
stimuli and follow different fates
29
. If this hypothesis were correct, PCD and differentiation of S. 18 
coelicolor would have to be blocked after 5-aza-dC treatment and in the SCO1731::Tn5062 mutant 19 
strain, and this is not the case. Notwithstanding it is possible that 5-aza-dC effect is temporary and 20 
that other methyltransferases or pathways are activated in the SCO1731::Tn5062 mutant strain. An 21 
alternative hypothesis about the biological role of cytosine methylation, is that it influences gene 22 
expression, as it occurs in other systems
14-16,23,45
. Methylation of cytosines in eukaryotic promoters 23 
leads to repression of transcription and to an activation when it affects gene bodies
45
. In E. coli the 24 
absence of the dcm gene leads to a differential expression of 510 genes, i.e. two ribosomal protein 25 
genes and the drug resistance transporter gene sugE, at stationary phase
14,15,16
. Future work will be 26 
addressed to identifying SCO1731 target genes and to comparing the methylome of S. coelicolor 27 
parental and the SCO1731::Tn5062 mutant strains. 28 
Overall, this is the first report that correlates DNA cytosine methylation with differentiation in S. 29 
coelicolor and attributes a DNA methyltransferase function to the SCO1731 gene. Our results show 30 
that both, the treatment with 5-aza-2’-deoxycytidine as well as the inactivation of the SCO1731 31 
gene, result in a strong impairment in morphological differentiation (delay in aerial mycelium and 32 
sporulation) and an impediment in actinorhodin production. Our results reveal, for the first time, 33 
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that epigenetics, through methylation of cytosines, control morpho-physiological differentiation in 1 
S. coelicolor unveiling new levels of complexity of gene expression and regulation in this 2 
microorganism.   3 
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Methods 1 
 2 
Bacterial strains and media. Bacterial strains, plasmids and cosmids are listed in Table 2 The 3 
strains were grown in sucrose-free R5A, GYM and SFM, and maintained by following procedures, 4 
reported in Manteca et al.
46
. Escherichia coli strains were grown at 37°C in solid or liquid 2xYT 
47
 5 
medium supplemented with the appropriate antibiotics. 6 
 7 
Dot Blot assay. Genomic DNAs were extracted by salting out procedures, as described in Lo 8 
Grasso et al.
48
. Dot blot assay was performed following the protocol described in Caracappa et al. 9 
49
. Briefly, genomic DNA was denatured at 95 °C for 10 min, spotted on nitrocellulose filter 10 
(Hybond ECL, GE Healthcare Life Sciences) and fixed by UV (2 cycles at 700 J). The spotted 11 
DNA was detected by staining the filter with 0.02% (w/v) methylene blue in 0.3 mol/L sodium 12 
acetate (pH 5.2). After removal of the staining solution, the methylated cytosines were detected 13 
using the anti-5-methylcytosine mouse antibody (Calbiochem) and the secondary goat anti-mouse 14 
IgG-H&L chain specific peroxidase conjugate (Calbiochem). The images were taken using 15 
Chemidoc (Chemi Hi sensitivity) and SuperSignal®West Femto maximum sensitivity substrate 16 
(Life Technologies). Spots of the same area were manually labelled and quantified by Molecular 17 
Imager ChemiDoc XRS System Biorad. Percentage of methylation level was reported as arbitrary 18 
units per mm
2
 (AU/mm
2
). The experiments were performed at least twice and in triplicate.  19 
Genomic DNAs, extracted from Escherichia coli DH10B and Escherichia coli ET12567/pUZ8002 20 
strains, were used as positive and negative control, respectively. The experiments were performed at 21 
least twice and in triplicate. 22 
 23 
5-aza-dC treatment. Preliminary experiments were performed to set up the demethylation. The 24 
amount of 5-aza-dC (Sigma) to add to the medium was chosen after checking the effect of 25 
increasing concentrations of the drug on the cells on solid medium GYM (Supplementary Fig. S3). 26 
5-azadC is reported to have a half-life of 20h-24h under conditions of physiological temperature 27 
and neutral pH
50
, so the treatment was repeated every 24h, from 0 to 96h. A control experiment was 28 
done in parallel using DMSO (the solvent of 5-aza-dC). 5 µM 5-aza-dC was the highest 29 
concentration in which the cells were still viable, while 10 and 15 were lethal for the cells, indeed a 30 
halo of growth inhibition was present. This is in accordance with results reported for E. coli
23
. 31 
In addition, a treatment was carried out to liquid cultures every 12 and 24h, from 0 to 36h. A control 32 
experiment was done in parallel using DMSO. The efficiency of demethylation was evaluated after 33 
48h of growth of S. coelicolor in the presence of 5 µM of 5-azadC added every 24h and 12h, by dot 34 
12 
 
blot analysis (Supplementary Fig. S4). The results revealed that the efficiency of the treatment 1 
carried out every 24h was 72%, while every 12h was 99,5%. Thus, for the demethylation 2 
experiments treatment was carried out with 5 µM 5-azadC added every 12h. 3 
 4 
Confocal laser scanning microscopy analysis (CLSM). Culture samples were processed for 5 
microscopy at different incubation time points following the protocol reported in Manteca et al. 
46
. 6 
Cells were stained with the LIVE/DEAD Bac-Light bacterial viability kit (Invitrogen), that contains 7 
the SYTO 9 green fluorescent stain for labelling all the cells and the non-cell-permeating nucleic 8 
acid stain (propidium iodide, PI) for detecting the dead cells. The samples were observed under a 9 
Leica TCS-SP2-AOBS confocal laser-scanning microscope at a wavelength of 488 nm and 568 nm 10 
excitation and 530 nm (green) or 640 nm (red) emissions. A significant number of images was 11 
analyzed in a minimum of three independent culture analyses. 12 
 13 
Antibiotic quantification. To measure actinorhodin (intracellular and extracellular), cells were 14 
broken in their culture medium by adding KOH 0.1 N. Cellular debris was discarded by 15 
centrifugation, and actinorhodin was quantified spectrophotometrically with UV/visible 16 
spectrophotometer, applying the linear Beer-Lambert relationship to estimate concentration 17 
(Ɛ640=25,320). Undecylprodigiosin was measured after vacuum drying of the mycelium, followed 18 
by extraction with methanol, acidification with HCl (to 0.5 N), and spectrophotometric assay at 530 19 
nm, again using the Beer-Lambert relationship to estimate concentration (Ɛ530=100,500). 20 
Reproducibility has been corroborated by at least three independent cultures at various 21 
developmental time points.  22 
 23 
Disruption of the SCO1731. To generate the SCO1731::Tn5062 mutant, the cosmid I11.2.G06 24 
containing a copy of the gene interrupted by the transposon Tn5062
41
 was used. It contains the 25 
apramycin and kanamycin resistance cassettes in the transposon and in the cosmid, respectively. 26 
After transformation by interspecific conjugation with E. coli ET12567/pUZ8002 as a donor strain, 27 
8 apramycin resistant colonies were obtained. Genomic DNA was extracted from 4 mutants and 28 
analyzed by PCR for the presence of apramycin (~1.3 kbp) and the absence of kanamycin (0.9 kbp) 29 
resistance cassette. The following primers were used Kana_F 5’-GATGGCTTTCTTGCCGCC3-’ 30 
and Kana_R 5’-TCGGTCATTTCGAACCCC-3’, Apra_F 5’-31 
CGGGGTACCCTCACGGTAACTGATGCC-3’ and Apra_R 5’-ATTTTAATGCGGATGTTGCG-32 
3’ to amplify apramycin or kanamycin resistance cassette, respectively. Two samples (SCO1731-3 33 
13 
 
and -4) had the expected profile (Supplementary Fig. S5) and they were analyzed by Southern Blot 1 
using genomic DNA digested with SalI and Tn5062 as a probe. 2 
The expected restriction profile of the mutant is shown in the Supplementary Fig. S6. Southern blot 3 
analysis revealed that both putative mutants SCO1731::Tn5062 had the expected restriction profile, 4 
two bands of approximately 2.8 and 2.7 kb. 5 
 6 
Complementation of SCO1731::Tn5062 mutation. A copy of SCO1731, placed under the control 7 
of its promoter was amplified via PCR using Phusion High-Fidelity DNA Polymerase (Thermo), 8 
using the primers 1731_SpeI F 5’-GGACTAGTTGGCTGCCTCCTTACGGAT-3’ and 1731_compl 9 
R 5’-AAGATATCGTCTGGACGAGGACGAGTTC-3’ and was then cloned into pCR™-Blunt II-10 
TOPO®. The sequences were checked via DNA sequencing using the M13 universal primers prior 11 
to subcloning them into pNG3
48
 constructing the plasmid pNG3-1731compl (Table 2). The plasmid 12 
was used to transform the mutant SCO1731 strain by interspecific conjugation generating the 13 
SCO1731_compl strain. Thus, 32 colonies of putative SCO1731_compl strain were obtained after 14 
the growth in SFM with hygromycin. After 3 passages of these colonies on GYM with hygromycin, 15 
genomic DNA was extracted by 10 putative complemented strains and analyzed by PCR using the 16 
primers SCO4848_F 5’-CGTCGATCCCCTCGGTTG-3’ and SCO4848_R. 5’-17 
GAGCCGGGAAAGCTCATTCA-3’. These primers amplified a fragment of 617 bp only if pNG3 is 18 
integrated at the attB site of SCO4848. Six of eight samples had the expected profile 19 
(Supplementary Fig. S7) and only the SCO1731_compl-8 was used for further experiment. 20 
  21 
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Figure legend 1 
Fig. 1: Methylation levels along the different growth phases of S. coelicolor, S. lividans, S. 2 
griseus and S. avermitilis.  3 
Genomic DNA was extracted from bacterial cultures grown both in liquid and on solid medium and 4 
analyzed by dot blot assay with antibody against 5MeC. Bars represent methylation levels in 5 
arbitrary units (AU) quantifying dot blot signal intensities. Error bars were obtained from three 6 
independent experiments. Dot blots are shown below the bars. MI and MII stages are indicated. a) 7 
solid cultures. b) liquid cultures. MII48h and MII72h correspond to aerial and sporulating aerial 8 
hyphae, respectively. 9 
 10 
Fig. 2 Effect of 5-aza-dC treatment on S. coelicolor morphological and physiological 11 
differentiation on solid GYM. 12 
a-b) CLSM analysis (LIVE/DEAD Bac-Light bacterial viability kit staining) of the untreated and 13 
treated cultures after 5, 7 and 8h from seeding of the same spore stock on GYM plates with or 14 
without 5-aza-dC. c) Percentage of spore germination after 5h, 7h, 8h and 9h of growth of untreated 15 
and treated cultures. d) Growth curves of untreated and treated cultures. e-f) CLSM analysis of 16 
untreated and treated cultures at 72 and 96h. g-h) Macroscopic view of undecylprodigiosin (red 17 
color) and actinorhodin (blue color) production of untreated and treated cultures at 50 and 72h on 18 
GYM plates. 19 
 20 
Fig. 3: Effect of 5-aza-dC treatment in sucrose-free liquid R5A cultures.  21 
a) Growth. b) Undecylprodigiosin production. c) Actinorhodin production. Continuous and dashed 22 
lines indicate the untreated and the treated culture, respectively. 23 
 24 
Fig. 4: Growth and cytosine methylation of the S. coelicolor wild-type strain, the 25 
SCO1731::Tn5062 mutant and the complemented SCO1731::Tn5062 mutant, in sucrose-free 26 
R5A cultures. 27 
a) Growth curves. b) cytosine methylation levels at 20-hours (MI). AU indicate arbitrary units of 28 
methylation levels. 29 
 30 
 31 
Comentario [AM11]: Revise that this is 
correct. It might be (a) 
Comentario [VA12]: Done  
Comentario [AM13]: Y axis in graph c 
starts on 0, but graphs a and b starts in a 
negative value. Please, unify it. It is not 
important, but is unusual.  
Comentario [VA14]: done 
Comentario [AM15]: Why not include 
the dot blot under the bars like in Fig. 1? 
Comentario [VA16]: done 
18 
 
Fig. 5: Actinorhodin production in sucrose-free R5A cultures of the S. coelicolor wild-type 1 
strain, the SCO1731::Tn5062 mutant and the SCO1731::Tn5062 complemented strain.  2 
Macroscopic view of laboratory flasks is shown at different developmental time points (48h, 72h 3 
and 96h). Blue color corresponds to actinorhodin; red colour corresponds to undecylprodigiosin. 4 
 5 
Fig. 6: Morphological differentiation of the S. coelicolor wild-type strain, the 6 
SCO1731::Tn5062 mutant and the SCO1731::Tn5062 complemented strain on GYM plates.  7 
Macroscopic view (left panels); CLSM images (right panels) taken after staining the cells with the 8 
LIVE/DEAD Bac-Light bacterial viability kit. Arrows indicate spore chains. 9 
  10 
Comentario [AM17]: Why the plate of 
the complemented strain at 48-hours is 
green?  
Comentario [VA18]: No idea! 
It was the picture 
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Table 1 List of putative methyltransferases annotated in S. coelicolor genome (StrepDB - The 1 
Streptomyces Annotation Server).  2 
Ratios of log2 of gene expression between MII24h/MI are reported. A negative ratio indicates that 3 
the gene is more transcribed in MI, a positive one that is more transcribed in MII 24h. The ratios 4 
were taken from Yagüe et al.
29
. 5 
Putative methyltransferase Log 2 Ratio MII24h/MI Expression phase 
SCO1731 -1.8623 MI 
SCO0190  -1.3723 MI 
SCO4504  -1.298 MI 
SCO1969 -1.1342 MI 
SCO7445 -0.8099 MI 
SCO5972 -0.6938 MI 
SCO0408  -0.5595 MI 
SCO2098  -0.3133 MI 
SCO5895 -0.3038 MI 
SCO3545 -0.2817 MI 
SCO2317  -0.2732 MI 
SCO2814  -0.2385 MI 
SCO3215 -0.2133 MI 
SCO7055 -0.1974 MI 
SCO2170  -0.1867 MI 
SCO2670  -0.1226 MI 
SCO5589 -0.1108 MI 
SCO1555  -0.0979 MI 
SCO5094  -0.0884 MI 
SCO6844 -0.0768 MI 
SCO0594  -0.0681 MI 
SCO0760 -0.0136 MI 
SCO0648  0.0093 MII 
SCO3744 0.1059 MII 
SCO2338  0.1692 MII 
SCO6541 0.2415 MII 
SCO1162  0.3867 MII 
SCO5146  0.4161 MII 
SCO0929 0.5308 MII 
SCO6549 0.6532 MII 
SCO6928 0.7393 MII 
SCO3452  0.7782 MII 
SCO0835 0.7845 MII 
SCO0826 0.8163 MII 
SCO7452 0.8841 MII 
SCO5257 1.3063 MII 
20 
 
SCO0392  2.0070 MII 
SCO0995 2.4922 MII 
 1 
Table 2. Bacterial strains, plasmids and cosmids used in this study. 2 
 3 
 Description Origin or 
reference 
Bacterial strains   
S. coelicolor M145 SCP1
-
SCP2
-
 
39 
S.coelicolor SCO1731::Tn5062 SCO1731::Tn5062, Am
R
 This study 
Streptomyces lividans 1326 SCP1
-
SCP2
-
 
39 
Streptomyces griseus NBRC 
102592  
 NBRC 
Streptomyces avermitilis ATCC 
31267 
 ATCC 
Escherichia coli DH10B  F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 
recA1 endA1 araD139 Δ(ara, leu)7697 ga/U ga/K λ- rpsL 
nupG  
Invitrogen  
Escherichia coli  
ET12567/pUZ8002  
F-dam-13::Tn9 dcm6 hsdM hsdR recF143 zjj201::Tn10 galK2 
galT22 ara14 lacY1 xyl-5 leuB6 
39 
Plasmid/Cosmid   
pCR™-Blunt II-TOPO® Zero Blunt® TOPO® PCR Cloning Kit, KmR Invitrogen 
pNG3 bla cloned into pNG1/HindIII/AvrII Hyg
R
, Amp
R
 
51
 
pQM5062 Plasmid containing eGFP Tn5062 
52
 
pNG3-1731compl pNG3 plasmid containing the ORF of SCO1731 This study 
I11.2.G06 I11 cosmid carrying I11.2.G06 transposant 
41
 
 4 
